Cargando…
Multimodal therapy in oligometastatic prostate cancer: A glimpse into the future?
Autores principales: | Knipper, Sophie, von Amsberg, Gunhild, Stolzenbach, Franziska, Steuber, Thomas, Heck, Matthias, Eiber, Matthias, Berliner, Christoph, Maurer, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Second Military Medical University
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099635/ https://www.ncbi.nlm.nih.gov/pubmed/33996487 http://dx.doi.org/10.1016/j.ajur.2020.05.001 |
Ejemplares similares
-
Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer
por: Babst, Christa, et al.
Publicado: (2022) -
PSMA PET-directed surgical metastasis-directed therapy in metachronous prostate cancer
por: Ambrosini, Francesca, et al.
Publicado: (2023) -
Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support
por: Falkenbach, Fabian, et al.
Publicado: (2023) -
EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate Cancer
por: Falkenbach, Fabian, et al.
Publicado: (2023) -
Primary Tumor Treatment in Oligometastatic Prostate Cancer: Radiotherapy Versus Radical Prostatectomy
por: Knipper, Sophie, et al.
Publicado: (2022)